Literature DB >> 33326421

Estimating the herd immunity threshold by accounting for the hidden asymptomatics using a COVID-19 specific model.

Shaurya Kaushal1, Abhineet Singh Rajput2, Soumyadeep Bhattacharya3, M Vidyasagar4, Aloke Kumar2, Meher K Prakash1,5, Santosh Ansumali1,3.   

Abstract

A quantitative COVID-19 model that incorporates hidden asymptomatic patients is developed, and an analytic solution in parametric form is given. The model incorporates the impact of lock-down and resulting spatial migration of population due to announcement of lock-down. A method is presented for estimating the model parameters from real-world data, and it is shown that the various phases in the observed epidemiological data are captured well. It is shown that increase of infections slows down and herd immunity is achieved when active symptomatic patients are 10-25% of the population for the four countries we studied. Finally, a method for estimating the number of asymptomatic patients, who have been the key hidden link in the spread of the infections, is presented.

Entities:  

Year:  2020        PMID: 33326421     DOI: 10.1371/journal.pone.0242132

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  6 in total

1.  Herd immunity: could it bring the COVID-19 pandemic to an end?

Authors:  Thomas Hugh Pennington
Journal:  Future Microbiol       Date:  2021-04-13       Impact factor: 3.165

2.  Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021.

Authors:  Marie C D Stoner; Frederick J Angulo; Sarah Rhea; Linda Morris Brown; Jessica E Atwell; Jennifer L Nguyen; John M McLaughlin; David L Swerdlow; Pia D M MacDonald
Journal:  Open Forum Infect Dis       Date:  2022-01-17       Impact factor: 3.835

Review 3.  Epidemiological challenges in pandemic coronavirus disease (COVID-19): Role of artificial intelligence.

Authors:  Abhijit Dasgupta; Abhisek Bakshi; Srijani Mukherjee; Kuntal Das; Soumyajeet Talukdar; Pratyayee Chatterjee; Sagnik Mondal; Puspita Das; Subhrojit Ghosh; Archisman Som; Pritha Roy; Rima Kundu; Akash Sarkar; Arnab Biswas; Karnelia Paul; Sujit Basak; Krishnendu Manna; Chinmay Saha; Satinath Mukhopadhyay; Nitai P Bhattacharyya; Rajat K De
Journal:  Wiley Interdiscip Rev Data Min Knowl Discov       Date:  2022-06-28

4.  Knowledge, Attitudes and Practices towards SARS-CoV-2 vaccination among morbid obese individuals: a pilot study.

Authors:  Matteo Riccò; Marina Valente; Giorgio Dalmonte; Federico Marchesi; Simona Peruzzi; Lucia Ballabeni; Concetta Prioriello
Journal:  Acta Biomed       Date:  2022-07-01

5.  Dynamical characterization of antiviral effects in COVID-19.

Authors:  Pablo Abuin; Alejandro Anderson; Antonio Ferramosca; Esteban A Hernandez-Vargas; Alejandro H Gonzalez
Journal:  Annu Rev Control       Date:  2021-05-28       Impact factor: 6.091

6.  High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Authors:  Susy Fanny Núñez-Zapata; Bruno Benites-Peralta; Percy Mayta-Tristan; Alfonso J Rodríguez-Morales
Journal:  Int J Infect Dis       Date:  2021-07-11       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.